Peripheral Neuropathy News and Research

RSS
Peripheral neuropathy describes damage to the peripheral nervous system, which transmits information from the brain and spinal cord to every other part of the body.

More than 100 types of peripheral neuropathy have been identified, each with its own characteristic set of symptoms, pattern of development, and prognosis. Impaired function and symptoms depend on the type of nerves -- motor, sensory, or autonomic -- that are damaged. Some people may experience temporary numbness, tingling, and pricking sensations, sensitivity to touch, or muscle weakness. Others may suffer more extreme symptoms, including burning pain (especially at night), muscle wasting, paralysis, or organ or gland dysfunction. Peripheral neuropathy may be either inherited or acquired. Causes of acquired peripheral neuropathy include physical injury (trauma) to a nerve, tumors, toxins, autoimmune responses, nutritional deficiencies, alcoholism, and vascular and metabolic disorders. Acquired peripheral neuropathies are caused by systemic disease, trauma from external agents, or infections or autoimmune disorders affecting nerve tissue. Inherited forms of peripheral neuropathy are caused by inborn mistakes in the genetic code or by new genetic mutations.
Research shows how loss of de-N-glycosylation enzyme causes detrimental effects

Research shows how loss of de-N-glycosylation enzyme causes detrimental effects

Normalizing cholesterol metabolism in microglia alleviates chronic neuropathic pain

Normalizing cholesterol metabolism in microglia alleviates chronic neuropathic pain

Novel CBD analog alleviates pain in mouse model of chemotherapy-induced peripheral neuropathy

Novel CBD analog alleviates pain in mouse model of chemotherapy-induced peripheral neuropathy

FDA approves immunotherapy for first-line treatment of advanced gastric cancer

FDA approves immunotherapy for first-line treatment of advanced gastric cancer

UTHSC professor awarded $1.79 million grant to develop new amyloidosis treatment

UTHSC professor awarded $1.79 million grant to develop new amyloidosis treatment

An increase in the risk of clinical sequelae after SARS-CoV-2 infection

An increase in the risk of clinical sequelae after SARS-CoV-2 infection

Discovery may help cancer patients to avoid chemotherapy's debilitating side effects

Discovery may help cancer patients to avoid chemotherapy's debilitating side effects

Study reveals potential risk factors for developing nerve damage after cancer treatment

Study reveals potential risk factors for developing nerve damage after cancer treatment

How SARS-CoV-2 enters the central nervous system

How SARS-CoV-2 enters the central nervous system

Unexpected neurologic complication identified in severe COVID-19

Unexpected neurologic complication identified in severe COVID-19

How COVID-19 affects the nervous system

How COVID-19 affects the nervous system

Dana-Farber nurse-scientists receive more than $1.3 million for two research projects

Dana-Farber nurse-scientists receive more than $1.3 million for two research projects

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

NUS researchers identify new protein to prevent chemotherapy-induced neuropathy

NUS researchers identify new protein to prevent chemotherapy-induced neuropathy

Scientists discover gene mutation involved in paraplegia and epilepsy

Scientists discover gene mutation involved in paraplegia and epilepsy

USF awarded $2.2 million to study neuromuscular effects of chemotherapy in breast cancer survivors

USF awarded $2.2 million to study neuromuscular effects of chemotherapy in breast cancer survivors

Raising Awareness of Coeliac Disease with Coeliac UK

Raising Awareness of Coeliac Disease with Coeliac UK

LMRI scientists discover cause of debilitating eye disease

LMRI scientists discover cause of debilitating eye disease

First genetic cause for a rare eye disease discovered

First genetic cause for a rare eye disease discovered

FDA approves new drug for specific type of highly treatment-resistant tuberculosis

FDA approves new drug for specific type of highly treatment-resistant tuberculosis